KhonKaenU
Khon Kaen, KhonKaen, 40000, Thailand
Completed
NCT Number: NCT06302023
Docosahexaenoic Acid (DHA) Supplementation During Pregnancy Reduces the Risk of Preterm Birth in Threatened Preterm Labor
The goal of this clinical trial is to learn about the effects of Docosahexaenoic acid (DHA) in reducing the incidence of premature birth in threatened preterm labor
The main questions it aims to answer are:
* Can DHA supplementation reduce the incidence of premature birth in threatened preterm labor? * How does DHA supplementation affect pregnancy outcomes? Participants were organized into two groups * Group 1 (Intervention) Participants will be asked to take a DHA 1000mg per day * Group 2 (control) Participant will not need to take a DHA
Completed
Looking for future studies?
Notify MeKey information
Age range
18 year and older
Sex eligibility
Female
Study type
Interventional
Phase
Phase 2
Primary location
About this study
Threatened preterm labor is defined as regular uterine contractions occurring before 37 completed weeks of gestation, without any cervical dilation.
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Singleton pregnancy
- Between 24 wk to 34 wk of gestational age
- Pregnant women diagnosed threatened preterm labor (with no cervical change)
Exclusion criteria
- Fetal anomalies
- Multiple pregnancy
- Premature rupture of membrane
- Placental disorders: placenta previa, placental abruption
- Fetal growth restriction
- Pregnancy complication: gestational diabetes mellitus, Chronic hypertension
- Allergic reaction to DHA
Treatment and study plan
Docosahexaenoic acid (DHA) 1000 mg
Dietary SupplementPregnant women will be ask to take a DHA 1000 mg per days at bedtime until delivery or 37 week of gestational age
Other names: NOW
Primary outcomes
-
Number of Participants with preterm birth
Time frame: at delivery time
Delivery at less than 37 weeks of gestational age
Secondary outcomes
-
Rate of low birth weight neonate
Time frame: at delivery time
Newborn's weight at birth is less than 2500g
-
Rate of Neonatal Intensive care unit admission
Time frame: at delivery time
newborn need neonatal intensive care
Sponsors and collaborators
Lead sponsor
Khon Kaen University
Other
Registry information
Important dates
- Study start
- 2024
- Primary completion
- 2024
- Study completion
- 2024
- First posted
- Mar 8, 2024
- Registry last updated
- Dec 12, 2024
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.